Paracrine functions of fibrocytes to promote lung fibrosis

References

• Chesney J, Bacher M, Bender A, Bucala R. The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc. Natl Acad. Sci. USA 94(12), 6307–6312 (1997).
   Google Scholar
• Chesney J, Metz C, Stavitsky AB, Bacher M, Bucala R. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J. Immunol. 160(1), 419–425 (1998).
   PubMed Web of Science ®Google Scholar
• Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol. Med. 1(1), 71–81 (1994).
   PubMed Web of Science ®Google Scholar
• Myllyharju J, Kivirikko KI. Collagens, modifying enzymes and their mutations in humans, flies and worms. Trends Genet. 20(1), 33–43 (2004).
   PubMed Web of Science ®Google Scholar
• Strieter RM, Keeley EC, Burdick MD, Mehrad B. The role of circulating mesenchymal progenitor cells, fibrocytes, in promoting pulmonary fibrosis. Trans. Am. Clin. Climatol. Assoc. 120, 49–59 (2009).
   Google Scholar
• Moore BB, Kolodsick JE, Thannickal VJ et al. CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am. J. Pathol. 166(3), 675–684 (2005).
   PubMed Web of Science ®Google Scholar
• Moore BB, Murray L, Das A, Wilke CA, Herrygers AB, Toews GB. The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. Am. J. Respir. Cell Mol. Biol. 35(2), 175–181 (2006).
   PubMed Web of Science ®Google Scholar
• Phillips RJ, Burdick MD, Hong K et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J. Clin. Invest. 114(3), 438–446 (2004).
   PubMed Web of Science ®Google Scholar
• Tourkina E, Bonner M, Oates J et al. Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide. Fibrogenesis Tissue Repair 4(1), 15 (2011).
   Google Scholar
• Rafii R, Juarez MM, Albertson TE, Chan AL. A review of current and novel therapies for idiopathic pulmonary fibrosis. J. Thorac Dis. 5(1), 48–73 (2013).
   PubMedGoogle Scholar
• Schmidt M, Sun G, Stacey M, Mori L, Mattoli S. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J. Immunol. 170, 380–389 (2003).
   Google Scholar
• Saunders R, Siddiqui S, Kaur D et al. Fibrocyte localization to the airway smooth muscle is a feature of asthma. J. Allergy Clin. Immunol. 123(2), 376–384 (2009).
   Google Scholar
• Wang CH, Huang CD, Lin HC et al. Increased circulating fibrocytes in asthma with chronic airflow obstruction. Am. J. Respir. Crit. Care Med. 178(6), 583–591 (2008).
   Google Scholar
• Bellini A, Marini MA, Bianchetti L, Barczyk M, Schmidt M, Mattoli S. Interleukin (IL)-4, IL-13, and IL-17A differentially affect the profibrotic and proinflammatory functions of fibrocytes from asthmatic patients. Mucosal. Immunol. 5(2), 140–149 (2012).
   PubMed Web of Science ®Google Scholar
• Mathai SK, Gulati M, Peng X et al. Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab. Invest. 90(6), 812–823 (2010).
   PubMed Web of Science ®Google Scholar
• Gan Y, Reilkoff R, Peng X et al. Role of semaphorin 7a signaling in transforming growth factor beta1-induced lung fibrosis and scleroderma-related interstitial lung disease. Arthritis Rheum. 63(8), 2484–2494 (2011).
   Google Scholar
• Tourkina E, Richard M, Oates J et al. Caveolin-1 regulates leucocyte behaviour in fibrotic lung disease. Ann. Rheum. Dis. 69(6), 1220–1226 (2010).
   Google Scholar
• Mehrad B, Burdick MD, Zisman DA, Keane MP, Belperio JA, Strieter RM. Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem. Biophys. Res. Commun. 353(1), 104–108 (2007).
   Google Scholar
• Andersson-Sjoland A, de Alba CG, Nihlberg K et al. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int. J. Biochem. Cell Biol. 40(10), 2129–2140 (2008).
   PubMed Web of Science ®Google Scholar
• Moeller A, Gilpin SE, Ask K et al. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 179(7), 588–594 (2009).
   PubMed Web of Science ®Google Scholar
• Fujiwara A, Kobayashi H, Masuya M et al. Correlation between circulating fibrocytes, and activity and progression of interstitial lung diseases. Respirology 17(4), 693–698 (2012).
   Google Scholar
• Naik PK, Bozyk PD, Bentley JK et al. Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 303(12), L1046–L1056. (2012).
   PubMed Web of Science ®Google Scholar
• Garibaldi BT, D'Alessio FR, Mock JR et al. Regulatory T cells reduce acute lung injury fibroproliferation by decreasing fibrocyte recruitment. Am. J. Respir. Cell Mol. Biol. 48(1), 35–43 (2013).
   Google Scholar
• Harris DA, Zhao Y, Lapar DJ et al. Inhibiting CXCL12 blocks fibrocyte migration and differentiation and attenuates bronchiolitis obliterans in a murine heterotopic tracheal transplant model. J. Thorac Cardiovasc. Surg. 145(3), 854–861 (2012).
   Google Scholar
• Field JJ, Burdick MD, DeBaun MR et al. The role of fibrocytes in sickle cell lung disease. PLoS ONE 7(3), e33702 (2012).
   Google Scholar
• LaPar DJ, Burdick MD, Emaminia A et al. Circulating fibrocytes correlate with bronchiolitis obliterans syndrome development after lung transplantation: a novel clinical biomarker. Ann. Thorac Surg. 92(2), 470–477 (2011).
   PubMed Web of Science ®Google Scholar
• Tanjore H, Xu XC, Polosukhin VV et al. Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis. Am. J. Respir. Crit. Care Med. 180(7), 657–665 (2009).
   PubMed Web of Science ®Google Scholar
• Wang JF, Jiao H, Stewart TL, Shankowsky HA, Scott PG, Tredget EE. Fibrocytes from burn patients regulate the activities of fibroblasts. Wound Repair. Regen. 15(1), 113–121 (2007).
   Google Scholar
• Bartram U, Speer CP. The role of transforming growth factor beta in lung development and disease. Chest 125(2), 754–765 (2004).
   PubMed Web of Science ®Google Scholar
• Schmidt M, Sun G, Stacey MA, Mori L, Mattoli S. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J. Immunol. 171(1), 380–389 (2003).
   PubMed Web of Science ®Google Scholar
• Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425(6958), 577–584 (2003).
   PubMed Web of Science ®Google Scholar
• Puthawala K, Hadjiangelis N, Jacoby SC et al. Inhibition of integrin alpha(v)beta6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis. Am. J. Respir. Crit. Care Med. 177(1), 82–90 (2008).
   PubMed Web of Science ®Google Scholar
• Rosenbloom J, Mendoza FA, Jimenez SA. Strategies for anti-fibrotic therapies. Biochim. Biophys. Acta 1832(7), 1088–1103 (2013).
   PubMed Web of Science ®Google Scholar
• Wipff PJ, Hinz B. Integrins and the activation of latent transforming growth factor beta1 - an intimate relationship. Eur. J. Cell Biol. 87(8–9), 601–615 (2008).
   PubMed Web of Science ®Google Scholar
• Iwamoto N, Distler JH, Distler O. Tyrosine kinase inhibitors in the treatment of systemic sclerosis: from animal models to clinical trials. Curr. Rheumatol. Rep. 13(1), 21–27 (2011).
   Google Scholar
• Arribillaga L, Dotor J, Basagoiti M et al. Therapeutic effect of a peptide inhibitor of TGF-beta on pulmonary fibrosis. Cytokine 53(3), 327–333 (2011).
   PubMed Web of Science ®Google Scholar
• Horan GS, Wood S, Ona V et al. Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation. Am. J. Respir. Crit. Care Med. 177(1), 56–65 (2008).
   PubMed Web of Science ®Google Scholar
• Quan TE, Cowper S, Wu SP, Bockenstedt LK, Bucala R. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int. J. Biochem. Cell Biol. 36(4), 598–606 (2004).
   PubMed Web of Science ®Google Scholar
• Pilling D, Fan T, Huang D, Kaul B, Gomer RH. Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS ONE 4(10), e7475 (2009).
   Google Scholar
• Huang C, Ogawa R. Fibroproliferative disorders and their mechanobiology. Connect Tissue Res. 53(3), 187–196 (2012).
   PubMed Web of Science ®Google Scholar
• Leitinger B, Hohenester E. Mammalian collagen receptors. Matrix Biol. 26(3), 146–155 (2007).
   PubMed Web of Science ®Google Scholar
• Olaso E, Arteta B, Benedicto A, Crende O, Friedman SL. Loss of discoidin domain receptor 2 promotes hepatic fibrosis after chronic carbon tetrachloride through altered paracrine interactions between hepatic stellate cells and liver-associated macrophages. Am. J. Pathol. 179(6), 2894–2904 (2011).
   PubMed Web of Science ®Google Scholar
• Levental KR, Yu H, Kass L et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139(5), 891–906 (2009).
   PubMed Web of Science ®Google Scholar
• Wipff PJ, Rifkin DB, Meister JJ, Hinz B. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J. Cell Biol. 179(6), 1311–1323 (2007).
   PubMed Web of Science ®Google Scholar
• Aiba S, Tagami H. Inverse correlation between CD34 expression and proline-4-hydroxylase immunoreactivity on spindle cells noted in hypertrophic scars and keloids. J. Cutan Pathol. 24(2), 65–69 (1997).
   Google Scholar
• Fontana L, Chen Y, Prijatelj P et al. Fibronectin is required for integrin alphavbeta6-mediated activation of latent TGF-beta complexes containing LTBP-1. FASEB J. 19(13), 1798–1808 (2005).
   Google Scholar
• Muro AF, Moretti FA, Moore BB et al. An essential role for fibronectin extra type III domain A in pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 177(6), 638–645 (2008).
   PubMed Web of Science ®Google Scholar
• Zuo F, Kaminski N, Eugui E et al. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc. Natl Acad. Sci. USA 99(9), 6292–6297 (2002).
   Google Scholar
• Oikonomidi S, Kostikas K, Tsilioni I, Tanou K, Gourgoulianis KI, Kiropoulos TS. Matrix metalloproteinases in respiratory diseases: from pathogenesis to potential clinical implications. Curr. Med. Chem. 16(10), 1214–1228 (2009).
   Google Scholar
• Swiderski RE, Dencoff JE, Floerchinger CS, Shapiro SD, Hunninghake GW. Differential expression of extracellular matrix remodeling genes in a murine model of bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 152(3), 821–828 (1998).
   PubMed Web of Science ®Google Scholar
• Hartlapp I, Abe R, Saeed RW et al. Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J. 15(12), 2215–2224 (2001).
   Google Scholar
• Garcia-de-Alba C, Becerril C, Ruiz V et al. Expression of matrix metalloproteases by fibrocytes: possible role in migration and homing. Am. J. Respir. Crit. Care Med. 182(9), 1144–1152 (2010).
   PubMed Web of Science ®Google Scholar
• Galligan CL, Fish EN. Circulating fibrocytes contribute to the pathogenesis of collagen antibody-induced arthritis. Arthritis Rheum. 64(11), 3583–3593 (2012).
   Google Scholar
• Xu J, Mora A, Shim H, Stecenko A, Brigham KL, Rojas M. Role of the SDF-1/CXCR4 axis in the pathogenesis of lung injury and fibrosis. Am. J. Respir. Cell Mol. Biol. 37(3), 291–299 (2007).
   Google Scholar
• van Deventer HW, Wu QP, Bergstralh DT et al. C-C chemokine receptor 5 on pulmonary fibrocytes facilitates migration and promotes metastasis via matrix metalloproteinase 9. Am. J. Pathol. 173(1), 253–264 (2008).
   Google Scholar
• Wert SE, Yoshida M, LeVine AM et al. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc. Natl Acad. Sci. USA 97(11), 5972–5977 (2000).
   Google Scholar
• Cabrera S, Gaxiola M, Arreola JL et al. Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin. Int. J. Biochem. Cell Biol. 39(12), 2324–2338 (2007).
   PubMed Web of Science ®Google Scholar
• Bornstein P, Sage EH. Matricellular proteins: extracellular modulators of cell function. Curr. Opin. Cell Biol. 14(5), 608–616 (2002).
   PubMed Web of Science ®Google Scholar
• Perbal B. CCN proteins: multifunctional signalling regulators. Lancet 363(9402), 62–64 (2004).
   PubMed Web of Science ®Google Scholar
• Leask A, Abraham DJ. The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem. Cell. Biol. 81(6), 355–363 (2003).
   PubMed Web of Science ®Google Scholar
• Abreu JG, Ketpura NI, Reversade B, De Robertis EM. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat. Cell Biol. 4(8), 599–604 (2002).
   PubMed Web of Science ®Google Scholar
• Sonnylal S, Shi-Wen X, Leoni P et al. Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis. Arthritis Rheum. 62(5), 1523–1532 (2010).
   Google Scholar
• Brigstock DR. Connective tissue growth factor (CCN2, CTGF) and organ fibrosis: lessons from transgenic animals. J. Cell Commun. Signal. 4(1), 1–4 (2010).
   Google Scholar
• Bonniaud P, Margetts PJ, Kolb M et al. Adenoviral gene transfer of connective tissue growth factor in the lung induces transient fibrosis. Am. J. Respir. Crit. Care Med. 168(7), 770–778 (2003).
   PubMed Web of Science ®Google Scholar
• Lipson KE, Wong C, Teng Y, Spong S. CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis. Fibrogenesis Tissue Repair. 5 Suppl 1, S24 (2012).
   Google Scholar
• Weng CM, Chen BC, Wang CH et al. The ET receptor mediates fibrocyte differentiation in chronic obstructive asthma: the involvement of CTGF. Am. J. Respir. Crit. Care Med. (2013).
   Google Scholar
• Horiuchi K, Amizuka N, Takeshita S et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J. Bone Miner. Res. 14(7), 1239–1249 (1999).
   PubMed Web of Science ®Google Scholar
• Okamoto M, Hoshino T, Kitasato Y et al. Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias. Eur. Respir. J. 37(5), 1119–1127 (2011).
   PubMed Web of Science ®Google Scholar
• Eckes B, Zweers MC, Zhang ZG et al. Mechanical tension and integrin alpha 2 beta 1 regulate fibroblast functions. J. Investig. Dermatol. Symp. Proc. 11(1), 66–72 (2006).
   Google Scholar
• Tschumperlin DJ, Jones JC, Senior RM. The fibrotic matrix in control: does the extracellular matrix drive progression of idiopathic pulmonary fibrosis? Am. J. Respir. Crit. Care Med. 186(9), 814–816 (2012).
   Google Scholar
• Sidhu SS, Yuan S, Innes AL et al. Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma. Proc. Natl Acad. Sci. USA 107(32), 14170–14175 (2010).
   Google Scholar
• Ozaki T, Hayashi H, Tani K, Ogushi F, Yasuoka S, Ogura T. Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 145(1), 85–91 (1992).
   Google Scholar
• Wardlaw AJ, Hay H, Cromwell O, Collins JV, Kay AB. Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J. Allergy Clin. Immunol. 84(1), 19–26 (1989).
   Google Scholar
• Wilborn J, Bailie M, Coffey M, Burdick M, Strieter R, Peters-Golden M. Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis. J. Clin. Invest. 97(8), 1827–1836 (1996).
   PubMed Web of Science ®Google Scholar
• Wilborn J, Crofford LJ, Burdick MD, Kunkel SL, Strieter RM, Peters-Golden M. Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J. Clin. Invest. 95(4), 1861–1868 (1995).
   PubMed Web of Science ®Google Scholar
• Vannella KM, McMillan TR, Charbeneau RP et al. Cysteinyl leukotrienes are autocrine and paracrine regulators of fibrocyte function. J. Immunol. 179(11), 7883–7890 (2007).
   Google Scholar
• Baud L, Perez J, Denis M, Ardaillou R. Modulation of fibroblast proliferation by sulfidopeptide leukotrienes: effect of indomethacin. J. Immunol. 138(4), 1190–1195 (1987).
   Google Scholar
• Phan SH, McGarry BM, Loeffler KM, Kunkel SL. Binding of leukotriene C4 to rat lung fibroblasts and stimulation of collagen synthesis in vitro. Biochemistry 27(8), 2846–2853 (1988).
   Google Scholar
• Scotton CJ, Chambers RC. Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest 132(4), 1311–1321 (2007).
   PubMed Web of Science ®Google Scholar
• Kisseleva T, Uchinami H, Feirt N et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J. Hepatol. 45(3), 429–438 (2006).
   PubMed Web of Science ®Google Scholar
• Vancheri C. Idiopathic pulmonary fibrosis: an altered fibroblast proliferation linked to cancer biology. Proc. Am. Thorac Soc. 9(3), 153–157 (2012).
   Google Scholar
• Leask A, Parapuram SK, Shi-Wen X, Abraham DJ. Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease? J. Cell Commun. Signal. 3(2), 89–94 (2009).
   PubMed Web of Science ®Google Scholar
• Naik PK, Bozyk PD, Bentley JK et al. Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 303(12), L1046–L1056 (2012).
   PubMed Web of Science ®Google Scholar
• Kim CF, Jackson EL, Woolfenden AE et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121(6), 823–835 (2005).
   PubMed Web of Science ®Google Scholar
• Rawlins EL, Okubo T, Xue Y et al. The role of Scgb1a1+ Clara cells in the long-term maintenance and repair of lung airway, but not alveolar, epithelium. Cell Stem Cell 4(6), 525–534 (2009).
   PubMed Web of Science ®Google Scholar
• Selman M, Pardo A. Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers. Proc. Am. Thorac Soc. 3(4), 364–372 (2006).
   Google Scholar
• Sisson TH, Mendez M, Choi K et al. Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 181(3), 254–263 (2010).
   PubMed Web of Science ®Google Scholar
• Wang R, Ibarra-Sunga O, Verlinski L, Pick R, Uhal BD. Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am. J. Physiol. Lung Cell Mol. Physiol. 279(1), L143–L151 (2000).
   PubMed Web of Science ®Google Scholar
• Hagimoto N, Kuwano K, Inoshima I et al. TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells. J. Immunol. 168(12), 6470–6478 (2002).
   PubMed Web of Science ®Google Scholar
• Rawlins EL, Okubo T, Que J et al. Epithelial stem/progenitor cells in lung postnatal growth, maintenance, and repair. Cold Spring Harb. Symp. Quant. Biol. 73, 291–295 (2008).
   Google Scholar
• Gomperts BN, Strieter RM. Stem cells and chronic lung disease. Annu. Rev. Med. 58, 285–298 (2007).
   PubMed Web of Science ®Google Scholar
• Mason RJ, Williams MC, Moses HL, Mohla S, Berberich MA. Stem cells in lung development, disease, and therapy. Am. J. Respir. Cell Mol. Biol. 16(4), 355–363 (1997).
   Google Scholar
• Rawlins EL, Hogan BL. Epithelial stem cells of the lung: privileged few or opportunities for many? Development 133(13), 2455–2465 (2006).
   PubMed Web of Science ®Google Scholar
• Kao HK, Chen B, Murphy GF, Li Q, Orgill DP, Guo L. Peripheral blood fibrocytes: enhancement of wound healing by cell proliferation, re-epithelialization, contraction, and angiogenesis. Ann. Surg. 254(6), 1066–1074 (2011).
   Google Scholar
• Schmeckebier S, Mauritz C, Katsirntaki K et al. Keratinocyte growth factor and dexamethasone plus elevated cAMP levels synergistically support pluripotent stem cell differentiation into alveolar epithelial type II cells. Tissue Eng. Part A 19(7–8), 938–951 (2013).
   PubMed Web of Science ®Google Scholar
• Takase HM, Itoh T, Ino S et al. FGF7 is a functional niche signal required for stimulation of adult liver progenitor cells that support liver regeneration. Genes Dev. 27(2), 169–181 (2013).
   PubMed Web of Science ®Google Scholar
• Fuchs Y, Steller H. Programmed cell death in animal development and disease. Cell 147(4), 742–758 (2011).
   PubMed Web of Science ®Google Scholar
• Kim KK, Kugler MC, Wolters PJ et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc. Natl Acad. Sci. USA 103(35), 13180–13185 (2006).
   Google Scholar
• Mani SA, Guo W, Liao MJ et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133(4), 704–715 (2008).
   PubMed Web of Science ®Google Scholar
• Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE 3(8), e2888 (2008).
   PubMed Web of Science ®Google Scholar
• Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112(12), 1776–1784 (2003).
   PubMed Web of Science ®Google Scholar
• Savagner P, Kusewitt DF, Carver EA et al. Developmental transcription factor slug is required for effective re-epithelialization by adult keratinocytes. J. Cell Physiol. 202(3), 858–866 (2005).
   Google Scholar
• Borie R, Quesnel C, Phin S et al. Detection of alveolar fibrocytes in idiopathic pulmonary fibrosis and systemic sclerosis. PLoS ONE 8(1), e53736 (2013).
   Web of Science ®Google Scholar
• Fontana L, Chen Y, Prijatelj P et al. Fibronectin is required for integrin alphavbeta6-mediated activation of latent TGF-beta complexes containing LTBP-1. FASEB J. 19(13), 1798 (2005).
   Google Scholar
• Munger JS, Huang X, Kawakatsu H et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96(3), 319–328 (1999).
   PubMed Web of Science ®Google Scholar
• Nemzek JA, Fry C, Moore BB. Adoptive transfer of fibrocytes enhances splenic T-cell numbers and survival in septic peritonitis. Shock 40(2), 106–114 (2013).
   Google Scholar
• Kolodsick JE, Toews GB, Jakubzick C et al. Protection from fluorescein isothiocyanate-induced fibrosis in IL-13-deficient, but not IL-4-deficient, mice results from impaired collagen synthesis by fibroblasts. J. Immunol. 172(7), 4068–4076 (2004).
   PubMed Web of Science ®Google Scholar
• Hanumegowda C, Farkas L, Kolb M. Angiogenesis in pulmonary fibrosis: too much or not enough? Chest 142(1), 200–207 (2012).
   PubMed Web of Science ®Google Scholar
• Agostini C, Gurrieri C. Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis. Proc. Am. Thorac Soc. 3(4), 357–363 (2006).
   Google Scholar
• Burdick MD, Murray LA, Keane MP et al. CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling. Am. J. Respir. Crit. Care Med. 171(3), 261–268 (2005).
   PubMed Web of Science ®Google Scholar
• Wan YY, Tian GY, Guo HS et al. Endostatin, an angiogenesis inhibitor, ameliorates bleomycin-induced pulmonary fibrosis in rats. Respir. Res. 14(1), 56 (2013).
   Google Scholar
• Hashimoto N, Phan SH, Imaizumi K et al. Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 43(2), 161–172 (2010).
   PubMed Web of Science ®Google Scholar
• Zeisberg EM, Tarnavski O, Zeisberg M et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 13(8), 952–961 (2007).
   PubMed Web of Science ®Google Scholar